Literature DB >> 22001977

Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats.

Kinga Burda1, Anna Czubak, Krzysztof Kus, Elżbieta Nowakowska, Piotr Ratajczak, Jennifer Zin.   

Abstract

Recent research has suggested that cognitive disorders are a persistent trait of mental illnesses such as schizophrenia. Cognitive deficits in the course of schizophrenia may be due to the disease and/or drug therapy, especially with old-generation drugs. Several clinical experiments have indicated the beneficial effects of new-generation antipsychotics on cognitive processes in patients treated for mental disorders. Aripiprazole is a new, atypical antipsychotic with a unique mechanism of action, which may have positive effects on cognitive functions. The aim of this study was to investigate the effects of aripiprazole on spatial memory in the Morris water maze and antidepressant activity in the Porsolt test. In addition, we examined whether aripiprazole had any side effects in the chimney test. The behavioral tests showed that aripiprazole improved spatial memory in rats and had antidepressant and anxiolytic effects after a single treatment; however, aripiprazole impaired motor coordination after repeated administration. We concluded that aripiprazole could be an effective antipsychotic for the treatment of patients with schizophrenia or bipolar disorder who have associated anxiety and cognitive deficits.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001977     DOI: 10.1016/s1734-1140(11)70605-3

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  11 in total

1.  Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.

Authors:  Jun Gao; Rongyin Qin; Ming Li
Journal:  J Psychopharmacol       Date:  2015-01-13       Impact factor: 4.153

2.  Evaluation of anxiolytic effects of aripiprazole and hydroxyzine as a combination in mice.

Authors:  Nikita Shekhar Sawantdesai; Pravin Popatrao Kale; Jay Savai
Journal:  J Basic Clin Pharm       Date:  2016-09

3.  Re-evaluation of the interrelationships among the behavioral tests in rats exposed to chronic unpredictable mild stress.

Authors:  Congli Hu; Ying Luo; Hong Wang; Shengnan Kuang; Guojuan Liang; Yang Yang; Shaoshan Mai; Junqing Yang
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

4.  Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke.

Authors:  Yu Ri Kim; Ha Neui Kim; Ki Whan Hong; Hwa Kyoung Shin; Byung Tae Choi
Journal:  Int J Mol Sci       Date:  2017-02-08       Impact factor: 5.923

5.  Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats.

Authors:  Batool Rahmati; Zahra Kiasalari; Mehrdad Roghani; Mohsen Khalili; Fariba Ansari
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

6.  Indoleamine 2,3-Dioxygenase-Dependent Neurotoxic Kynurenine Metabolism Contributes to Poststroke Depression Induced in Mice by Ischemic Stroke along with Spatial Restraint Stress.

Authors:  Young Soo Koo; Hyunha Kim; Jung Hwa Park; Min Jae Kim; Yong-Il Shin; Byung Tae Choi; Seo-Yeon Lee; Hwa Kyoung Shin
Journal:  Oxid Med Cell Longev       Date:  2018-12-30       Impact factor: 6.543

7.  Long-term Effects of Aripiprazole Treatment during Adolescence on Cognitive Function and Dopamine D2 Receptor Expression in Neurodevelopmentally Normal Rats.

Authors:  Hyung Jun Choi; Soo Jung Im; Hae Ri Park; Subin Park; Chul-Eung Kim; Seunghyong Ryu
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-08-31       Impact factor: 2.582

8.  Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism.

Authors:  Nermin Eissa; Karthikkumar Venkatachalam; Petrilla Jayaprakash; Priya Yuvaraju; Markus Falkenstein; Holger Stark; Bassem Sadek
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-27

9.  Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.

Authors:  Trisha Chakrabarty; Shane J McInerney; Ivan J Torres; Benicio N Frey; Roumen V Milev; Daniel J Müller; Susan Rotzinger; Sidney H Kennedy; Raymond W Lam
Journal:  CNS Drugs       Date:  2021-03-08       Impact factor: 5.749

10.  Aripiprazole exerts a neuroprotective effect in mouse focal cerebral ischemia.

Authors:  Chan H Gil; Yu R Kim; Hong J Lee; Da H Jung; Hwa K Shin; Byung T Choi
Journal:  Exp Ther Med       Date:  2017-11-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.